Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-047810
Filing Date
2025-03-31
Accepted
2025-03-31 16:35:37
Documents
6
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 S-8 srzn_s-8_20250331.htm S-8 185356
2 EX-5.1 srzn-ex5_1.htm EX-5.1 23224
3 EX-23.1 srzn-ex23_1.htm EX-23.1 5671
4 EX-FILING FEES srzn-exfiling_fees.htm EX-FILING FEES 32025
5 GRAPHIC img200110477_0.jpg GRAPHIC 5964
6 GRAPHIC img200110477_1.jpg GRAPHIC 5964
  Complete submission text file 0000950170-25-047810.txt   264200
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286269 | Film No.: 25793946
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)